inXso 2021 MedTech Series – R&D focal points

Beijing sky scraper & cctv tower

Schedule for inXso 2021 MedTech Series | R&D Focal Points

six„MedTech R&D Focal Points“ – free introductory webinar series

For 2021 inXso has created a webinar series outlining some specific features that are essential for global design of medical technology, and introduces some regulatory aspects in context of EU MDR and Swiss regulatory landscape, as well as some basic features from Chinese and Japanese regulations that everyone – or every company – considering these healthcare markets should now of.

The schedule spans through the year 2021 with one webinar every two months, it has all together 6 sessions of which three focuses on development and three regulatory aspects:

  • six 45min lectures + 15min question round
  • 1 in every two months through the year 2021 (check schedule)
  • Introducing Japanese and Chinese regulatory requirements and essentials
  • How does the medical device regulations work between Switzerland and EU
  • Human Factors Engineering process in international design integrated with Risk Management
  • Design V&V in aligned cross-national regulatory framework
  • Cross-cultural and cross-national design – what do you need to consider?

 

Attendee registration link

Participation requires registration via Eventbrite and for further inquiries please contact info@inxso.pro

Life Science & Medical Technology EXPO’s in Asia 2022 – Where you should start

Expos, trade fairs, and shows are a way to build business networks and search for partners that open new potential markets. It brings a lot of positive exposure for companies and their innovations, builds customer interest, and opens doors for collaborative projects along the life science and medical technology value chain.

Horizon Europe Cluster Health – Research and Innovation Funding

The EU Research and Innovation Programme 2021-2027 has gathered a lot of attention from the research communities around Europe this time around with their Cluster Health topics that are open for proposals. The published destinations aim to address acute and long-term problems in the healthcare ecosystem and the health and well-being of citizens from a societal point of view – without forgetting the lessons learned from the Covid-19 pandemic.

inXso 2021 MedTech Series – R&D focal points

For 2021 inXso has created a webinar series outlining some specific features that are essential for global design of medical technology, and introduces some regulatory aspects in context of EU MDR and Swiss regulatory landscape, as well as some basic features from Chinese and Japanese regulations that everyone – or every company – considering these healthcare markets should now of.

How to build internationalization strategy for HealthTech

It is a known fact that most internationalization attempts fail due to lack of thorough preparation and adhering to the chosen strategy.

When it comes to life sciences – healthcare technology, biomedical technology and pharmaceuticals – that is an industry operating in a heavily regulated environment, any attempt to seek market growth through internationalization faces a multitude of specific considerations.

User-Centered Design of Medical Devices

In recent years medical technology has taken a trend towards creating personalized care while seeking ways to enhance quality for patients and to lower healthcare costs. At the same time developers have to keep in mind the ease of use of the devices and gaining regulatory approval for them in the highly internationalized market.

The Internationalization Challenge of Biomedical Innovations

The life science industry distinguishes itself from other high-technology industries with such fundamental dimensions as applying scientific knowledge to provide technological solutions aiming to improve health care and quality of life – in a highly regulated environment. At the same time, usually purchasing decisions are not made by end-consumers, but their physicians or such third party as an insurance company, for example.

Apply for HealthTech Online Pitching

On 22nd May an online pitching for HealthTech Startups is organized by inXso together with Slush China to Venture Capital investors of which there is a significant participation from the Chinese Venture Capital investment companies focused on HealthTech, BioPharma and BioMedTech.

What are the Key Points of Chinese Health Tech Initiatives – Join Discussion on May 29th

In our series focusing on Health Tech in Chinese market inXso is organizing an interactive webinar “Health Tech China Focus” together with Tampere HealthHUB that will briefly discuss some of the key points and rather unique aspects of Chinese Health Tech initiatives and their implementation.

Office

Biokatu 12, FinnMedi 5

33520 Tampere

Finland